Ishiba Hiroshi, Sumida Yoshio, Kataoka Seita, Kuroda Masaaki, Akabame Satoshi, Tomiyasu Kiichiro, Tanaka Muhei, Arai Masahiro, Taketani Hiroyoshi, Seko Yuya, Okajima Akira, Hara Tasuku, Umemura Atsushi, Nishikawa Taichiro, Yamaguchi Kanji, Moriguchi Michihisa, Mitsuyoshi Hironori, Yasui Kohichiroh, Itoh Yoshito
Departments of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine.
Department of Gastroenterology, Kyoto Yamashiro General Medical Center.
Hepatol Res. 2016 Oct;46(11):1107-1117. doi: 10.1111/hepr.12665. Epub 2016 Mar 15.
Cardiovascular events are the leading cause of death among patients with non-alcoholic fatty liver disease (NAFLD), but their relationship remains unclear. This study examined the association between coronary atherosclerosis and liver fibrosis, represented by the coronary artery calcification (CAC) score and non-invasive fibrosis markers, respectively.
Among 698 patients with chest pain or electrocardiographic abnormalities who underwent coronary computed tomography (CT) between April 2006 and March 2010, those with known liver disorders or history of emergency coronary angioplasty were excluded, leaving 366 patients for this study. Diagnosis of NAFLD was based on abdominal CT and history of alcohol consumption. Subjects with CAC of 100 AU or more were categorized into the high-risk group for cardiovascular events. Patient records were examined for clinical parameters including CAC score and non-invasive fibrosis marker FIB-4 index.
Ninety-four patients (25.7%) had NAFLD. In this group, univariate analysis identified old age, high diastolic blood pressure, high liver to spleen ratio and high FIB-4 index as risk factors for cardiovascular events and multivariate analysis identified age of 66 years or older and FIB-4 index of 2.09 or more as the significant risk factors. For the observation period until August 2014, the cumulative proportion of PCI performance was significantly higher in patients with FIB-4 of 2.09 or more than those with FIB-4 of less than 2.09.
The progression of arteriosclerosis and that of liver fibrosis may be associated in NAFLD patients. The FIB-4 index can be easily determined and thus can be a useful marker for predicting cardiovascular events in NAFLD patients.
心血管事件是非酒精性脂肪性肝病(NAFLD)患者的主要死因,但其关系仍不明确。本研究分别以冠状动脉钙化(CAC)评分和非侵入性纤维化标志物为代表,探讨冠状动脉粥样硬化与肝纤维化之间的关联。
在2006年4月至2010年3月期间接受冠状动脉计算机断层扫描(CT)的698例胸痛或心电图异常患者中,排除已知肝脏疾病或有急诊冠状动脉血管成形术史的患者,本研究共纳入366例患者。NAFLD的诊断基于腹部CT和饮酒史。CAC为100 AU或更高的受试者被归类为心血管事件高危组。检查患者记录中的临床参数,包括CAC评分和非侵入性纤维化标志物FIB-4指数。
94例患者(25.7%)患有NAFLD。在该组中,单因素分析确定老年、高舒张压、高肝脾比和高FIB-4指数为心血管事件的危险因素,多因素分析确定66岁及以上年龄和FIB-4指数2.09及以上为显著危险因素。至2014年8月的观察期内,FIB-4指数2.09及以上的患者PCI治疗的累积比例显著高于FIB-4指数低于2.09的患者。
NAFLD患者的动脉硬化进展与肝纤维化进展可能相关。FIB-4指数易于测定,因此可作为预测NAFLD患者心血管事件的有用标志物。